208 related articles for article (PubMed ID: 27465322)
1. Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
Yu Q; Liu ZY; Chen Q; Lin JS
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):494-500. PubMed ID: 27465322
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
[TBL] [Abstract][Full Text] [Related]
3. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
Jiang C; Long J; Liu B; Xie X; Kuang M
Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
[TBL] [Abstract][Full Text] [Related]
4. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1.
He H; Tian W; Chen H; Deng Y
Mol Med Rep; 2016 Feb; 13(2):1923-9. PubMed ID: 26718267
[TBL] [Abstract][Full Text] [Related]
7. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
8. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
Ou Y; Zhai D; Wu N; Li X
Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
[TBL] [Abstract][Full Text] [Related]
10. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
[TBL] [Abstract][Full Text] [Related]
11. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
12. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
13. PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy.
Zheng JF; He S; Zeng Z; Gu X; Cai L; Qi G
Mol Ther; 2019 Oct; 27(10):1784-1795. PubMed ID: 31337603
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
15. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.
Fleischer B; Schulze-Bergkamen H; Schuchmann M; Weber A; Biesterfeld S; Müller M; Krammer PH; Galle PR
Int J Oncol; 2006 Jan; 28(1):25-32. PubMed ID: 16327976
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
[TBL] [Abstract][Full Text] [Related]
18. 17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells.
Zhao S; Li H; Jiang C; Ma T; Wu C; Huo Q; Liu H
J Bioenerg Biomembr; 2015 Oct; 47(5):373-81. PubMed ID: 26323360
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]